PRESS RELEASE published on 08/14/2026 at 07:00, 3 months 6 days ago Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency European Medicines Agency validates Pfizer and Valneva's MAA for Lyme Disease Vaccine Candidate based on Phase 3 results. Potential game-changer in Lyme disease prevention Valneva Lyme Disease Vaccine Pfizer European Medicines Agency Phase 3 VALOR Trial
PRESS RELEASE published on 08/13/2026 at 07:00, 3 months 7 days ago Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates Valneva SE reports half-year 2026 financial results, maintains full-year guidance, strengthens cash position, and provides corporate updates. Live webcast of results conference call available Financial Results Revenue Valneva SE Half-year Corporate Updates
BRIEF published on 07/22/2026 at 17:50, 3 months 28 days ago Valneva to Announce First Half 2026 Financial Results Financial Results Forward-looking Statements Webcast Vaccine Development Market Approvals
PRESS RELEASE published on 07/22/2026 at 17:45, 3 months 28 days ago Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026 Valneva SE to report First Half 2026 Consolidated Financial Results on August 13, 2026. The live webcast will discuss financial results and provide a business update Financial Results Business Update Valneva SE Live Webcast Vaccine Company
BRIEF published on 06/25/2026 at 17:50, 4 months 24 days ago Valneva Confirms Leadership Changes at Annual General Meeting Annual General Meeting Leadership Change Valneva SE Shareholder Resolutions Biopharmaceutical Governance
PRESS RELEASE published on 06/25/2026 at 17:45, 4 months 24 days ago Valneva Announces Successful Outcome of its Annual General Meeting Valneva SE announces successful outcome of its Annual General Meeting in Lyon, France. Dr. Gerd Zettlmeissl appointed as Chair of the Board of Directors. Key resolutions passed Board Of Directors Annual General Meeting Lyon Valneva SE Dr. Gerd Zettlmeissl
BRIEF published on 05/18/2026 at 17:24, 6 months 1 day ago Valneva SE Maintains Buy Rating Despite Sales Decline FDA Approval BUY Rating Valneva SE Lyme Vaccine Q1 2026 Results
PRESS RELEASE published on 05/18/2026 at 17:19, 6 months 1 day ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Valneva SE (ISIN: FR0004056851) research, maintains Buy recommendation with lowered price target. Q1/26 sales declined by 37.2% to €30.9m. Market awaiting Pfizer's BLA submission for Lyme disease vaccine candidate LB6V Buy Recommendation Research Update Valneva SE Q1/26 Sales Pfizer BLA Submission
BRIEF published on 05/06/2026 at 11:41, 6 months 13 days ago Valneva announces the publication of its financial results for the first quarter of 2026 Financial Results Web Conference Clinical Development Valneva Vaccines
PRESS RELEASE published on 05/06/2026 at 11:36, 6 months 13 days ago Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 Valneva SE to report First Quarter 2026 Consolidated Financial Results on May 13, 2026. Live webcast available for discussion and business update Financial Results Business Update Valneva SE Live Webcast Vaccine Company
Published on 11/20/2026 at 02:00, 8 hours 8 minutes ago PPX Mining Announces Completion of Debt Settlement
Published on 11/19/2026 at 23:30, 10 hours 38 minutes ago EQ Inc. Reports Third Quarter 2026 Financial Results
Published on 11/19/2026 at 23:00, 11 hours 8 minutes ago Redwood AI Reports Positive Interim Q-SAFE Findings Supporting Quantum-Assisted Chemical Safety Screening
Published on 11/19/2026 at 22:35, 11 hours 33 minutes ago Pampa Medina Drilling Intersects 102m of 1.0% Cu and 5.1g/t Ag from SPRD-21; 22m of 2.1% Cu and 10g/t Ag from SPRD-18; and 8m of 3.21% Cu and 27.5g/t Ag from SPRD-24
Published on 11/19/2026 at 22:25, 11 hours 43 minutes ago Kidoz Reports Record Nine-Month Revenue of US$9,900,750
Published on 11/20/2026 at 09:56, 11 minutes ago Emerald Horizon - IEA World Energy Outlook 2026: Summer Drought Exposes Limits of Legacy Nuclear Plants – Europe Needs Its Own Energy Technology Now
Published on 11/20/2026 at 09:30, 37 minutes ago Invitation to the 21st International Investment Forum on December 9, 2026: International investment ideas as the year draws to a close
Published on 11/20/2026 at 09:21, 46 minutes ago EQS-Adhoc: Bitcoin Group SE: Removal of Management Board member Moritz Eckert
Published on 11/20/2026 at 09:05, 1 hour 2 minutes ago Sailun Group Attends COP31, Showcasing Green Practices Driven by Technological Innovation
Published on 11/20/2026 at 09:01, 1 hour 6 minutes ago Original-Research: NFON AG (von NuWays AG): BUY
Published on 11/19/2026 at 19:00, 15 hours 8 minutes ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 1 day 1 hour ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 07:30, 1 day 2 hours ago Gimv invests in SpiraTec, a specialist in automation and digital transformation for the process industry